Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence. Review uri icon

Overview

abstract

  • BACKGROUND: Adults with serious mental illness have a mortality rate two to three times higher than the overall US population, much of which is due to somatic conditions, especially cardiovascular disease. Given the disproportionately high prevalence of cardiovascular risk factors in the population with SMI, screening for these conditions is an important first step for timely diagnosis and appropriate treatment. This comprehensive literature review summarizes screening rates for cardiovascular risk factors in the population with serious mental illness. METHODS: Relevant articles published between 2000 and 2013 were identified using the EMBASE, PsychInfo, PubMed, SCOPUS and Web of Science databases. We reviewed 10 studies measuring screening rates for obesity, diabetes, dyslipidemia, and hypertension in the population with serious mental illness. Two reviewers independently extracted information on screening rates, study population, and study setting. RESULTS: Rates of screening varied considerably by time period, study population, and data source for all medical conditions. For example, rates of lipid testing for antipsychotic users ranged from 6% to 85%. For some conditions, rates of screening were consistently high. For example, screening rates for hypertension ranged from 79% - 88%. CONCLUSIONS: There is considerable variation in screening of cardiovascular risk factors in the population with serious mental illness, with significant need for improvement in some study populations and settings. Implementation of standard screening protocols triggered by diagnosis of serious mental illness or antipsychotic use may be promising avenues for ensuring timely diagnosis and treatment of cardiovascular risk factors in this population.

publication date

  • March 21, 2015

Research

keywords

  • Cardiovascular Diseases
  • Mental Disorders

Identity

PubMed Central ID

  • PMC4376086

Scopus Document Identifier

  • 84925834131

Digital Object Identifier (DOI)

  • 10.1017/S003329171100105X

PubMed ID

  • 25885367

Additional Document Info

volume

  • 15